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Abstract
Background: Tissue engineering of vascularised skeletal muscle is a promising method for the
treatment of soft tissue defects in reconstructive surgery. In this study we explored the
characteristics of novel collagen and fibrin matrices for skeletal muscle tissue engineering. We
analyzed the characteristics of newly developed hybrid collagen-I-fibrin-gels and collagen nanofibers
as well as collagen sponges and OPLA®-scaffolds. Collagen-fibrin gels were also tested with genipin
as stabilizing substitute for aprotinin.
Results: Whereas rapid lysis and contraction of pure collagen I- or fibrin-matrices have been great
problems in the past, the latter could be overcome by combining both materials. Significant
proliferation of cultivated myoblasts was detected in collagen-I-fibrin matrices and collagen
nanofibers. Seeding cells on parallel orientated nanofibers resulted in strongly aligned myoblasts. In
contrast, common collagen sponges and OPLA®-scaffolds showed less cell proliferation and in
collagen sponges an increased apoptosis rate was evident. The application of genipin caused
deleterious effects on primary myoblasts.
Conclusion: Collagen I-fibrin mixtures as well as collagen nanofibers yield good proliferation rates
and myogenic differentiation of primary rat myoblasts in vitro In addition, parallel orientated
nanofibers enable the generation of aligned cell layers and therefore represent the most promising
step towards successful engineering of skeletal muscle tissue.
Background
Finding a suitable matrix has been a crucial step and still
represents one of the main obstacles for tissue engineering
of skeletal muscle [1-4]. Especially in the field of skeletal
muscle tissue engineering there are great demands to be
met in terms of biocompatibility, three-dimensional fab-
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rication and above all the right balance of elasticity, stabil-
ity and degradation. Several attempts have been pursued
to test suitable materials with various consistencies, such
as gels [5,6] , sponges [7] e.g. and most recently also elec-
trospun nanofibers [8-12]. In this study our first aim was
to develop and establish novel biocompatible matrices for
myoblast cultivation. Furthermore, we intended to
directly compare these novel matrices with varying differ-
ent consistencies and micromorphologies to established
tissue engineering matrices which had not yet been
applied in skeletal muscle generation. Finally we wanted
to assess and identify their advantages and disadvantages
as matrices for skeletal muscle tissue engineering.
On one hand, collagen is a very promising material, espe-
cially for engineering of muscle tissue, since it mimics the
natural extracellular matrix very closely and may thus con-
tribute to myoblast proliferation and differentiation [13].
On the other hand pure collagen-gels show contraction of
the matrix within 1–2 days [1]. To achieve more stability,
we introduce a hybrid collagen-I-fibrin-gel in muscle tis-
sue engineering research [14-16].
Biocompatibility in vivo is an essential demand on every
matrix used for tissue engineering and therefore the appli-
cation of materials such as Matrigel™ [17,18] or chicken
embryo extract [19] was excluded in this study. In all our
experiments we only used biocompatible materials which
are also appropriate for clinical application. The use of
fibrin-gels implicates the application of aprotinin as a
fibrinolysis inhibitor. Aprotinin, however, has shown
some allergenic potential in clinical trials [20,21]. We
therefore tried to substitute aprotinin with genipin, which
is an herbal substance that generates increased crosslink-
ing of fibrin molecules and thereby delays degradation
[22-24].
In this study a collagen-sponge containing a combination
of several collagens was also evaluated for the purpose of
skeletal muscle tissue engineering. Due to its irregular
pore-size and high elasticity, it seemed to be a promising
matrix and has only recently been introduced in skeletal
muscle tissue engineering [7]. Additionally, we tested
OPLA® (open-cell poly-lactic-acid) a synthetic material,
which was evaluated successfully for bone tissue engineer-
ing [25].
As the most promising potential matrix for skeletal mus-
cle tissue engineering we developed electrospun collagen-
I nanofibers. Particularly the possibility of processing par-
allel aligned fibers is a very promising property for engi-
neering parallelly aligned muscle cells or even myotubes
[26]. Therefore, pure collagen nanofibers with an average
diameter of 550 nm were used for in vitro skeletal muscle
tissue engineering. Hence collagen I was electrospun par-
allel aligned with nonwoven collagen I nanofibers as con-
trol. Proliferation, differentiation and apoptosis of
primary expanded rat myoblasts on different 3D-matrices
were evaluated. Furthermore, degradation and matrix sta-
bility as well as micromorphology of the different matri-
ces were assessed in order to determine the most
promising matrix for 3D engineering of skeletal muscle
tissue.
Results
Cell proliferation, matrix stability and statistical 
evaluation
Four groups of collagen-I-fibrin gels were evaluated (table
1): 5,0 mg/ml fibrin gels seeded with either 100.000 cells
(group 1) or 500.000 cells (group 2) and gels with 2,5 mg/
ml fibrin concentration also containing 100.000 cells
(group 3) or 500.000 cells (group 4). In group 1 and 2,
cell count showed only a slight increase of cell number
over a period of 14 days. In contrast, the gels with a fibrin
concentration of 2,5 mg/ml showed a significant increase
of cell number (p < 0,05) after 14 days when seeded with
100.000 cells (figure 1). In gels with the same composi-
tion, but seeded with 500.000 cells, we could detect an
even stronger increase in number of cells. The cell number
did not increase (seeded with 100.000 cells) or was even
decreased (500.000 cells) in collagen sponges.
The stability of the collagen-I-fibrin matrices, as judged by
the time of lysis of the matrix, showed a diametrically
opposing behavior. The stability of fibrin-collagen gels
was decreased with lower fibrin concentrations. However,
in every group of fibrin-collagen gels the stability
decreased over time until complete lysis occurred after day
21 (group 1 and 2), day 16 (group 3) or day 14 (group 4).
Control scaffolds composed of 5,0 mg/ml or 2,5 mg/ml
fibrin and 0,25 mg/ml collagen without cells clearly dis-
played higher stability (over 32 days for 5,0 mg/ml fibrin
and 27 days for 2,5 mg/ml fibrin). There was a signifi-
cantly higher proliferation of cells in the low fibrin groups
(group 3 and 4) after 14 days as opposed to the other
groups (groups 1 and 2) as assessed by one way ANOVA
test with the Bonferroni correction for multiple compari-
sons.
The collagen sponges showed no shrinkage and no lysis
within 4 weeks, so specimens were harvested after 4 weeks
as the latest time point.
On the collagen nanofibers the cells adhered to the matrix
as quickly as within 3–6 hours. The matrix was completely
overgrown by cells after 10 days and cell proliferation, as
measured by DAPI staining, was constant.BMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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Cell proliferation in collagen-I-fibrin gel and collagen sponges Figure 1
Cell proliferation in collagen-I-fibrin gel and collagen sponges. Group 3 and 4 (2,5 mg fibrin) showed satisfactory and 
significant (* p < 0,05) cell proliferation after two weeks. No significant cell proliferation could be detected in the collagen 
sponges.
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Table 1: Evaluation of four groups of collagen-I-fibrin gels
Matrix Seeded cells Fibrin-concentration
Collagen I-fibrin gel Group 1 100.000 5,0 mg/ml
Group 2 500.000 5,0 mg/ml
Group 3 100.000 2,5 mg/ml
Group 4 500.000 2,5 mg/ml
Collagen sponge 100.000/500.000
OPLA 100.000/500.000
Collagen nanofibers 2D 20.000BMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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Cell viability and differentiation
In every matrix we could detect MyoD- and desmin-posi-
tive cells after 5 or 7 days, as determined by positive
immunocytochemistry (figure 2). Apoptosis rates,
assessed by TUNEL-assay (figure 3), ranged from 7% to
80%. The lowest apoptosis rate with only 7% was
observed in the collagen-I fibrin gel containing aprotinin
(group 4) which was used as a control. In gels with geni-
pin-cross-linking, over 30% of the cells were apoptotic
using 10 μl genipin. In gels containing 100 μl genipin (fig-
ure 4) apoptosis was significantly higher at 80%. No sig-
nificant difference between peripheral sections (10 – 100
μm from the surface of the scaffold) and central sections
was detected in the collagen-I fibrin gel groups.
Surprisingly, apoptosis rate in the collagen sponges were
also high, ranging between 45% and 66% after four days
in culture both significantly higher than the control
group. The collagen sponges analyzed after 4 days in cul-
ture revealed a considerable difference between peripheral
and central sections: The sponges seeded with 500.000
cells presented higher apoptosis rates in the middle, i.e.
54,7% (± 25,6 SDM) apoptotic cells in central sections
versus 28,4% ± 19,9 SDM on the surface. In contrast to
this expected result, the collagen sponges seeded with
100.000 cells revealed an increased apoptosis rate on the
surface (76,4% ± 27,2 SDM on the surface versus 56,6% ±
18,2 SDM in the centre). Considering the high standard
deviation of the mean, an interpretation of these findings
is arguable. In contrast, OPLA® showed low apoptosis
rates between 26% and 8% and showed no significant dif-
ference to the control group.
TUNEL-assay of collagen-I nanofibers showed no apop-
totic cells. All cells that were adherent to the matrix after
four days in culture, were also DAPI-positive and fluores-
cein-negative. Due to the open structure of the nanofiber
matrix non-adherent cells are washed out during medium
exchange and washing steps before fixation. Thus non-
adherent cells are not accounted for apoptosis analysis by
the TUNEL-assay.
Scanning electron microscopy (SEM) and phase contrast 
microscopy
SEM-analysis of the collagen sponges showed an irregular
structure with varying pore sizes (figure 5). After 7 days of
culture the structure became more dense and clotted. Cells
could be detected on the surface of the matrix, adhering
directly to the matrix (figure 5b). Most cells were not
evenly spread out like cells growing on collagen-I
nanofibers but had a rather spheroidal shape. Phase con-
trast microscopy of collagen-I-fibrin gels confirmed that
the cells were evenly spread over the whole matrix after
the seeding procedure (figure 6). Surprisingly, the colla-
gen-I-fibrin gel also showed micro fibrils forming a
sponge-like structure in SEM analysis.
Due to dissolution of OPLA® in acetone, no SEM data
could be taken after cell seeding and cultivation, but SEM-
images of the dry matrix showed a rigid and sharply edged
surface (figure 7).
Compared to the orientated collagen-I nanofibers, SEM
images of the nonwoven nanofibers showed a more flat-
tened structure with smaller pore sizes (figure 8). Three
days after seeding, the collagen-I nanofibers were com-
pletely overgrown with cells. A parallel alignment of
myoblasts on orientated collagen-I nanofibres (figure 9)
could be observed via phase contrast microscopy. This
alignment was confirmed by scanning electron micros-
copy (figure 9c, d).
Light-Cycler-PCR
After two weeks in culture (figure 10), desmin was 4-fold
up-regulated (± 0,41 cycles) in group 1 of the collagen-I-
fibrin gels and also MyoD (21,11-fold ± 0,58) and MEF-
2d (8,88-fold ± 0,37) were clearly up-regulated in relation
to neonatal muscle tissue. Group 3 also showed a distinct
over-expression of MyoD (6,06-fold ± 0,54) and MEF-2d
(12,13-fold ± 0,98) but only slight up-regulation of
desmin (1,57-fold ± 0,52). In contrast, in group 2 desmin
(0,03-fold ± 0,36) and MyoD (0,16-fold ± 0,29) were
down-regulated whereas MEF-2-expression (1,11-fold ±
0,05) was nearly equal to neonatal muscle tissue. In group
4 desmin (0,03-fold ± 0,09) and MyoD (0,03-fold ± 0,92)
were down-regulated but MEF-2d was nearly 3-fold over-
expressed (2,93 ± 0,05) in relation to the calibrator. In
collagen sponges the amount of extractable mRNA was
too low and therefore excluded from analysis, the same
observation was made in OPLA®  scaffolds. Collagen-I
nanofibers developed in this study are two-dimensional,
thus gene expression levels of myogenic mRNA was
regarded as not comparable to those found in three-
dimensional collagen-I-fibrin gel matrices.
Discussion
Muscle tissue is frequently employed in plastic surgery for
reconstructive purposes through transplantation of pedi-
cled or free microvascular muscle flaps. Muscle transfer to
treat muscle and soft tissue defects usually results in sig-
nificant donor site morbidity. Tissue engineering of skele-
tal muscle could open new perspectives for reconstructive
surgery by avoiding harvest of muscle tissue at the donor
site. Therapy of congenital and degenerative muscle dis-
eases could also benefit from findings in muscle tissue
engineering research [27,28]. Natural components of the
extracellular matrix like different collagen types seem to
be suitable materials as matrix for culturing myoblasts.
Furthermore, matrix components like fibrin or collagen
have the advantage of clinical applicability and are there-
fore more attractive regarding regulatory issues compared
to Matrigel™ matrix e.g. [29]. However, high contraction
of pure collagen [30] or fibrin [5] gels has limited theirBMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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Immunocytochemistry Figure 2
Immunocytochemistry. 2D-culture of myoblasts before implantation, 400× (A+B). A: for MyoD (red); B: for desmin 
(green); blue: nucleic counterstain with DAPI. C-E: myoblasts cultivated over 7 days in different matrices, immunostaining for 
desmin (green) and DAPI counterstain, arrows: desmin-positive myoblasts, arrow heads: unspecific fluorescence of the matrix. 
Ccollagen-I-fibrin gel, 400×. D: collagen sponge, 200×. E: OPLA, 400×. F: myoblasts after 24 hours on orientated collagen-I 
nanofibers, 400×.BMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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application in vivo. Interestingly, the hybrid collagen-I-
fibrin-gel analyzed in this study showed no contraction
while significant cell proliferation and myoblast differen-
tiation was evident. Expectedly, the parametric one way
ANOVA-test showed significantly higher cell proliferation
in the low-fibrin groups (group 3 and 4) after 14 days in
culture than group 1 and 2 with twofold higher fibrin con-
centration. This is in accordance with the observations
published by Cassell and Morrison et al [17] , who used
pure fibrin gels with higher fibrin concentrations.
Surprisingly, quantitative PCR of muscle specific markers
showed that expression rates did not correlate with differ-
ent fibrin concentration rates but were rather associated
with the number of cells seeded initially though this vari-
able has been carefully controlled by using the same
amount of total RNA. Desmin, MyoD and MEF-2d were
clearly over-expressed in gels with low cell concentration
(100.000 cells, group 1 and 3) but in contrast, high cell
concentration (500.000 cells, group 2 and 4) provoked
down-regulation of desmin and MyoD and slight up-reg-
ulation of MEF-2d in case of group 4. These findings sug-
gest that muscle differentiation and gene expression also
depend on cell-cell interactions and therefore the initial
cell number may have a considerable influence on myob-
last differentiation and tissue development. However,
these results should be confirmed by further investiga-
tions. Additionaly, the use of GAPDH as endogenous con-
trol might be a limitation of the gene expression analysis.
The variable of different fibrin concentrations is known to
affect the expression rates of different genes. Just recently,
Hong et al. demonstrated the influence of fibrin on the
expression of collagen III and integrin ß3 in smooth mus-
cle cells [31]. But at least to our knowledge varying fibrin
concentrations in the range of 0,5 mg/ml versus 0,25 mg/
ml does not effect GAPDH expression directly and is also
not expected to influence the expression indirectly via
parameters such as diffusion, gas exchange or mechanical
properties of the matrix.
Unfortunately, the combination of collagen and fibrin
gels did not provide enough stability required for in
vivoapplication. In this context, crosslinking fibrin hydro-
gels with genipin appeared to be a good alternative to
aprotinin to enhance the stability and possibly eliminate
the allergenic risk at the same time. Unfortunately, our
results showed increased apoptosis of the seeded cells
depending on genipin concentrations, whereas in the con-
trol-samples (group 4) containing aprotinin a low apop-
tosis rate of 7% was found. A recent study proved a
cumulative cytotoxicity of high concentrations of genipin
(10 mM) in collagen gels [22]. Our results also confirm
these findings for collagen-I-fibrin gels and for the lower
concentration of 6 mM (10 μl genipin in the collagen-
fibrin matrix).
In case of the tested collagen sponge, we did not detect sig-
nificant cell proliferation even after four weeks in culture.
The high density of the sponge after cultivation in
medium could possibly be a reason for the high apoptosis
rate of over 45% after 4 days in culture. Our results sup-
port the hypothesis that high density of a matrix may
result in high apoptosis rates or low proliferation of
myoblasts [32].
Analysis of OPLA® proved to be difficult and remained
limitative. Hence, no detailed conclusion regarding quan-
titative proliferation or gene expression could be drawn.
After all OPLA® as a synthetic material showed no particu-
lar advantage for muscle tissue engineering. The material
may be well adapted for tissue engineering of bone tissue
due to its inflexibility, but for muscle tissue engineering
elasticity of OPLA® is not sufficient.
In the past collagen has been electrospun with additives
like PEO or elastin but these additives resulted in thinning
(PEO) or breakage (elastin) of the fibers [8]. The
nanofiber matrix we tested in this study was therefore
composed of pure collagen I and showed a satisfying cell
proliferation and maintenance of myogenic phenotype
on both, orientated and unorientated nanofibers. The
rapid adherence of the cells indicates a sufficient biocom-
patibility of the material. Additionally, orientation of the
fibers seemed to provoke parallel aligned cell prolifera-
tion on every sample. The myoblasts were observed to ori-
entate throughout the whole matrix. This phenomenon
was described by various studies and can be explained as
consequence of contact guidance. The contact guidance
TUNEL-assay Figure 3
TUNEL-assay. Dead cells are stained with fluorescein 
(green), vital cells are stained with DAPI (blue), after 4 weeks 
of cultivation all cells are fluorescein-positive in the collagen 
spongeBMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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theory was well defined by Curtis et al [33] as reaction of
the growing cell to discontinuities of the underlying sub-
stratum. Thus, the direction of developing pseudopodia
and therefore cell growth can be directed by highly orien-
tated matrices. Although Huber et al. [26] obtained orien-
tated myotubes also on nylon 6/6 nanofibers, this
synthetic material is not biodegradable and therefore
unsuitable for clinical application. Furthermore, pre-coat-
ing of the nylon fibers with Matrigel® was necessary to ena-
ble cell attachment. A similar approach was made by
Riboldi et al, using highly polyesterurethane microfibres
(DegraPol®) with Matrigel® coating for their experiments
[34]. They could also achieve myotube formation but in
contrast to nylon 6/6, polyesterurethane is biodegradable.
Unfortunately, the Matrigel®  coating is necessary for
DegraPol® also to enhance cell attachment, which repre-
sents the limitation of the work. This difficulty is avoided
by electrospinning collagen-I nanofibers which combine
biodegradability with rapid cell attachment and resem-
bles the natural ECM particularly better than the afore
mentioned materials.
Limitations of this work
The comparison of entirely different matrices such as gels,
nanofibers and sponges has to encounter the difficulty
that the physical properties of the matrices like stiffness/
elasticity, stability, diffusion of nutrients, pore size and
many others differ in a wide range. Materials like collagen
sponges and OPLA® are already well characterized, hence
the physical and chemical characterization has been lim-
ited to a minimum. Also fibrin and collagen gels as well as
electrospun collagen I-nanofibres have been described in
further details in previous studies. As a new approach this
study tries to evaluate potential matrices with entire differ-
ent structures for their practicability for muscle tissue
engineering in a realistic clinical setting. But leaving out
Matrigel coating or avoiding the use of cell lines as well as
high-passage primary cells are great challenges and under
Statistic analysis Figure 4
Statistic analysis. Apoptosis rate after four days in culture in collagen sponges (Cs) seeded with different cell concentrations 
and collagen-I-fibrin gel with different genipin concentrations (G) and control group containing aprotinin. Brackets indicate sig-
nificant differences assessed by student's t-test (p < 0,05). Error bars: standard deviation of the mean.
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such strict conditions the most basic demands on a possi-
ble matrix, i.e. sufficient stability, low apoptosis rates and
high proliferation, cannot be met by various materials,
which were successfully tested before under more aca-
demic conditions. Additionally, differentiation and even
maintenance of myogenic phenotype of primary cells iso-
lated from adult muscle tissue is a greater challenge than
culturing cell lines like C2C12 or L6 which are used in a
great number of studies. We therefore concentrated on the
basic parameters such as proliferation rate, apoptosis and
maintenance of myogenic phenotype rather than on fur-
ther differentiation e.g. myotubes formation.
Conclusion
Though collagen is known to be a suitable material for tis-
sue engineering of skeletal muscle due to its resemblance
to the natural extracellular matrix, our results confirm that
the consistency of a matrix has a great influence on cell
proliferation and differentiation. Despite its good bio-
compatibility the analyzed collagen sponge and also the
SEM of the collagen sponges Figure 5
SEM of the collagen sponges. Surface of the dry sponge before cell seeding, 200× (A) After cell seeding: arrow-head: cell 
adhering to collagen fibrils, 2500× (A).
A: phase contrast microscopy of collagen-I-fibrin gel: 24 hours after seeding the cells (arrow-heads) and gel formation, some of  the cells are already spread out (arrows), 100× B-C: SEM of the collagen-I fibrin gel after 10 days in culture media, 5000× (B)  and 25.000× (C) after fixation for SEM and drying procedure the gel showed micro fibrils forming a sponge-like structure Figure 6
A: phase contrast microscopy of collagen-I-fibrin gel: 24 hours after seeding the cells (arrow-heads) and gel formation, 
some of the cells are already spread out (arrows), 100× B-C: SEM of the collagen-I fibrin gel after 10 days in culture media, 
5000× (B) and 25.000× (C) after fixation for SEM and drying procedure the gel showed micro fibrils forming a sponge-like 
structure.  BMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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OPLA®-scaffolds seem to be unsuitable for myoblast culti-
vation. In the collagen-I-fibrin gel high proliferation rates
were yielded, while concomitant degradation of the
matrix was observed. Further enhancement of the stability
of the collagen-I-fibrin gel could result in a promising
matrix for amorphic tissues.
Though two dimensional and still in its early stages, elec-
trospun pure collagen-I nanofibers offer the unique prop-
erty of parallel alignment of the cells in accordance to the
contact guidance phenomenon. As the parallel orienta-
tion of differentiated myoblasts or myotubes, respectively,
is one of the most important properties of a suitable
SEM of dry OPLA-scaffolds (after in vitro culture OPLA-scaffolds dissolve during SEM-fixation) Figure 7
SEM of dry OPLA-scaffolds (after in vitro culture OPLA-scaffolds dissolve during SEM-fixation). A: 42×. B: 
250×.
SEM of unorientated collagen-I-nanofibers Figure 8
SEM of unorientated collagen-I-nanofibers. A: nanofibers without cells, the fibers show a more flattened structure with 
smaller pore sizes than orientated nanofibers, 5000×. B: nanofibers 3 days after seeding (arrows: cells), 1000×.BMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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matrix, we conclude that orientated nanofibres composed
of collagen-I may be the most promising matrix for mus-
cle tissue engineering at the moment.
Materials and methods
Cell isolation and culture
Primary rat myoblasts were isolated as previously
described [35]. Briefly, the hind limbs' skeletal muscle of
adult Lewis-rats was minced and digested first in 0,1% col-
lagenase solution (Biochrom AG, Berlin, Germany) for 1
h and then with trypsin-EDTA (PAA Laboratories GmbH,
Pasching, Austria) for 30 minutes at 37°C. After digestion
the solution was filtered through cell strainers (Falcon, BD
Biosciences, Bedford, MA, USA) with 70 μm pore size. The
flow-through was centrifuged and the pellet was resus-
pended in DMEM (Dulbecco's Modified Eagle Medium
Gibco/Invitrogen, Auckland, NZ) containing 10% FBS
(fetal bovine serum) and 1% P/S (Penicillin/Streptomy-
cin, Biochrom AG, Berlin, Germany), referred to as growth
medium. The cells were then seeded in 75 cm2-culture
flasks (Corning Incorporated, NY, USA), which had been
coated with 10 mg/ml gelatin solution (Biochrom AG,
Berlin, Germany) prior to seeding. The medium was
changed every second day. For all experiments, myoblasts
Phase contrast microscopy, cells indicated by arrow-heads Figure 9
Phase contrast microscopy, cells indicated by arrow-heads. A: 24 hours after cell seeding most cells are already spread 
out, 300×. B: 7 days after cell seeding the cells grow in parallel alignment, 300×. SEMof orientated collagen-I-nanofibers after 3 
days in culture. C: orientated collagen-I-nanofibers without cells, 5000×. D: parallel aligned cells on orientated nanofibers, 
500×.BMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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after the second passage were used. The ratio of myogenic
cells in P1-cultures was determined by immunostaining
for MyoD and desmin as described later (figure 2).
3D culture in collagen-I-fibrin-gels
Cells were detached from culture plates with trypsin-
EDTA and centrifuged at 2000 rpm. After discarding the
supernatant, the cells were resuspended in growth
medium. Fibrinogen (Tisseel VH S/D kit, Baxter AG,
Vienna, Austria) was dissolved according to the manufac-
turer's instructions and was used at a concentration of
either 20 mg/dl (group 1 and 2) or 10 mg/dl (group 3 and
4). The fibrinogen solution was then mixed 1:1 with
either 100.000 (group 1 and3) or 500.000 cells (group 2
and 4), aprotinin (3000 KU/ml,) and growth medium.
The collagen solution as provided in 0.02 N acetic acid
(rat tail collagen type I, BD Biosciences, Bedford, MA,
USA) was subsequently diluted with sterile water (aqua ad
injectabilia, B. Braun AG, Melsungen, Germany) to a con-
centration of 1 mg/ml and further diluted with DMEM 2×
(Invitrogen Corp., Karlsruhe, Germany) containing 20%
FBS and 2% P/S to a concentration of 0,5 mg/ml. The pH
was equilibrated to 7,0 with NaOH. Afterwards the fibrin-
ogen-cell-solution and the collagen solution were mixed
1:1 and pipetted into 24-well-plates (Corning Incorpo-
rated, NY, USA) and 6 IU thrombin per ml fibrinogen
(Tisseel-kit, Baxter AG, Vienna, Austria,) were added to the
wells. Each specimen had a volume of 0,7 ml (height:
approximately 0,8 cm, diameter: 1,5 cm), collagen-con-
centration of 0,25 mg/ml, fibrin-concentration of either
Quantitative PCR: Expression of desmin, MyoD and MEF-2d in collagen-I-fibrin gels Figure 10
Quantitative PCR: Expression of desmin, MyoD and MEF-2d in collagen-I-fibrin gels. Group 1: desmin was 4-fold 
up-regulated (± 0,41 cycles), MyoD (21,11-fold ± 0,58) and MEF-2d (8,88-fold ± 0,37) were also clearly up-regulated in relation 
to neonatal muscle tissue. Group 3: over-expression of MyoD (6,06-fold ± 0,54) and MEF-2d (12,13-fold ± 0,98) but only slight 
up-regulation of desmin (1,57-fold ± 0,52). Group 2: desmin (0,03-fold ± 0,36) and MyoD (0,16-fold ± 0,29) down-regulated, 
MEF-2-expression (1,11-fold ± 0,05) was nearly equal to neonatal muscle tissue. Group 4: down-regulation of desmin (0,03-fold 
± 0,09) and MyoD (0,03-fold ± 0,92), MEF-2d was nearly 3-fold over-expressed (2,93 ± 0,05).
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5,0 mg/ml or 2,5 mg/ml (table 1) and 731 KU aprotinin
per specimen. The collagen-fibrin clots were totally gelled
after 30 minutes and were then covered with growth
medium. After the second day, growth medium was
replaced with DMEM containing 2% donor horse serum
(DHS, Biochrom AG, Berlin, Germany) and 1% P/S.
Cell viability/TUNEL-assay
For this experiment, collagen-I fibrin gels were composed
as in group 4 (table 1). However, instead of aprotinin,
genipin solution (Wako Chemicals GmbH, Neuss, Ger-
many) at a concentration of 10 mg/ml was added in quan-
tities of 10, 21, 56, 100 μl to the resuspended cells. The
clots as well as collagen sponges were seeded with either
100.000 or 500.000 cells and harvested after 4 days in cul-
ture. Paraffin sections were taken from two defined
regions of each of the specimens, one peripheral and one
central section.
Sections were stained using the fluorescein DNA fragmen-
tation detection kit (FragEL kit, Calbiochem/Merck Bio-
sciences, Darmstadt, Germany) according to the
manufacturer's instructions, digitally photographed and
evaluated by ImageJ-program. Apoptosis rate was calcu-
lated as the ratio of apoptotic cells to total cell number. All
groups were tested against the control group (group 4,
containing aprotinin) and the two-tailed student's t-test
was used for statistical analysis. Results were considered
significant when p-value was less than 0,05.
Immunohistochemistry
Cryosections were performed after 1, 2, 3, 4, 5 and 7 days
and stained for two muscle-specific markers – MyoD and
desmin – to assess cell differentiation and DAPI (Diami-
dine-phenylindole-dihydrochloride, Applied Science/
Roche, Indianapolis; IN, USA) as nucleic counterstain.
First, sections were fixed in methanol, blocked with 5%
FBS/0,25% TritonX 100 (Sigma Aldrich, St. Louis, MO,
USA) in PBS (PBS-Dulbecco 1×, Biochrom AG, Berlin,
Germany) for 30 minutes and rinsed with PBS. Then sec-
tions were covered with the primary antibody for desmin
(monoclonal mouse IgG, Dako Cytomation, Carpinteria,
CA, USA) or MyoD (polyclonal rabbit IgG, Santa Cruz
Biotechnology, CA, USA) and incubated for 2 hours. After
rinsing the slides with PBS, the secondary antibody
against mouse (goat anti-mouse, cy-2-conjugated, Jackson
ImmunoResearch, Suffolk, UK) and rabbit respectively
(goat anti-rabbit, cy-3-conjugated) were added and incu-
bated for 1 hour. Finally, the specimens were counter-
stained with DAPI for 30 minutes and slides were covered
with mounting media (Fluoprep, Biomérieux, Marcy
l'Etoile, France). The slides were evaluated and digitally
photographed with fluorescence microscopy (Leitz
DMRBE and camera, Leica Microsystems, Wetzlar, Ger-
many).
Cell proliferation
To measure the cell proliferation rate, specimens of every
group were harvested on day 1, 2, 3, 4, 5, 7 and 14 and
embedded in paraffin. From every specimen four sections
were done in a standardized fashion: two from the periph-
eral (10–100 μm to the surface) and two from the central
part of the 3D-construct. Sections were subsequently
stained with DAPI and four images were recorded of every
slide. The number of DAPI-stained cells was counted
semi-automatically with ImageJ program. For statistical
analysis parametric one way ANOVA with repeated meas-
urements was used with the Tukey post hoc test for multi-
ple comparisons.
Collagen sponge
Collagen sponges were provided by BD Biosciences (Col-
lagen Composite, Bedford, MA, USA) and were composed
of bovine collagens type I and III. Physical characteristics
of the collagen sponges: 3 mm height, diameter of 5 mm,
average pore size: 100–200 μm. The sponges were placed
into 24-well plates and incubated in growth medium for
45 minutes at 37°C. Sponges were seeded with either
100.000 cells or 500.000 cells by pipetting the resus-
pended cells directly onto the matrix which was then cov-
ered with growth medium. After 24 hours the sponges
were transferred into new wells to prevent cells adherent
to the bottom of the wells from growing into the matrix.
Further treatment was the same as described for the fibrin-
collagen gels. The collagen sponges were harvested after 7
and 14 days in culture. Immunochemistry for MyoD and
desmin and DAPI staining for statistical evaluation of the
cell proliferation rate as well as the assessment of apopto-
sis rates after 4 days by TUNEL-assay were performed as
described for the fibrin-collagen gels. Additionally, the
collagen sponges were evaluated by scanning electron
microscopy (Quanta 200, FEI Company, Hillsboro, USA).
Therefore, sponges were first fixed with paraformaldehyd
then dehydrated in acetone and finally dried with the crit-
ical point method, using liquid CO2  as exchanging
medium (CPD 030, Bal-Tec AG, Liechtenstein). Prior to
SEM-analysis the samples were sputtered with gold (SCD
040, Bal-Tec AG, Liechtenstein).
OPLA® scaffolds
OPLA® scaffolds were also provided by BD Biosciences
(Collagen Composite, Bedford, MA, USA). The scaffold
was synthesized from D, D, L, L-polylactic acid. Physical
dimensions of the scaffold: 4 mm high, 4,5 mm in diam-
eter. Approximately 100–200 μm was quoted as the aver-
age pore size of the OPLA scaffolds. Modulus of elasticity
was assessed by the supplier and valued 0,92 ± 0,03 MPa.
Seeding procedure and cultivation of the OPLA® scaffolds
and collagen sponges were identical. However, OPLA® dis-
solved completely in ethanol and acetone and fixation forBMC Biotechnology 2009, 9:34 http://www.biomedcentral.com/1472-6750/9/34
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SEM and paraffin sections was therefore not possible.
Thus, our analysis of OPLA® was limited to SEM of dry
OPLA® scaffolds for evaluation of surface property, immu-
nocytochemistry of cryosections and analysis of apoptosis
rate.
Electrospinning of collagen nanofibres and cell seeding
The electrospinning process was performed as previously
described [10]. Collagen nanofibres were electrospun par-
allel aligned or without alignment as control. Bovine col-
lagen type I (Sigma-Aldrich, Taufkirchen, Germany) was
dissolved in hexafluoroisopropanol (Sigma-Aldrich,
Taufkirchen, Germany) at a concentration of 5% w/v
(needle bore size: 0,6 mm, distance between needle tip
and counter electrode: 12 cm). A voltage of 12 kV was
applied and the nanofibers were then deposited as non-
wovens on glass plates (16 mm diameter) fixed on the
counter electrode. For orientated nanofibres, the glass
plates were fixed to a roll rotating at 3500 rpm. The sam-
ples were then incubated for 1 h in vacuum at room tem-
perature and afterwards heated slowly to 110°C for 120 h.
The samples were cooled down to room temperature over-
night and framed with a brim of PLLA (Poly-L-lactid, 4%
wt, Boehringer Ingelheim Pharma GmbH, Ingelheim,
Germany) to prevent the nanofibers from floating off the
glass plates. At last the samples were plasma-sterilized
with H2O2.
Shortly before cell seeding, the collagen nanofibers were
soaked in DMEM for 30 minutes. The scaffolds were
placed in 12-well plates and 100 μl growth medium con-
taining 20.000 myoblasts in passage 3 were then pipetted
directly onto each scaffold. After incubation at 37°C for
2h the wells were filled with 2ml growth medium. The
scaffolds were transferred to new wells 24h after seeding.
Cultivating conditions were equal to the other matrices.
Nanofibre constructs were evaluated by phase contrast
microscopy (Fluovert FU, Leica Microsystems, Wetzlar,
Germany), immunochemistry and scanning electron
microscopy as described above.
RNA isolation, cDNA synthesis and Light-Cycler-PCR
In the four groups of collagen-I-fibrin gels the expression
rates of desmin, MyoD and MEF-2d (table 2) were ana-
lyzed. Gene expression in other matrices were not ana-
lyzed since the differences in mechanical and chemical
properties of gel matrices, sponges and two-dimensional
matrices are expected to be too great to control for a sen-
sible quantitative PCR setting. Total RNA isolated from
skeletal muscle tissue of newborn Lewis rats was used as
calibrator because neonatal muscle tissue, in contrast to
adult muscle tissue, is known to present a high expression
of the muscle specific markers desmin, MoyD and MEF-2d
and GAPDH was chosen as endogenous control. For every
group, five scaffolds were harvested after 14 days in cul-
ture, frozen in liquid nitrogen and ground with mortar
and pestle. RNA was then isolated via QiaShredder and
Micro-RNeasy-kit (Qiagen GmbH, Hilden, Germany)
according to the manufacturer's instructions. Concentra-
tion and purity of the pooled RNA was assessed for every
group photometrically by 260/230-ratio and 260/280-
ratio using an Eppendorf Biophotometer (Eppendorf AG,
Hamburg, Germany). Only mRNA with sufficient 260/
280 and 260/230-ratio was reverse-transcribed with Sen-
siscript®-RT-kit and oligo-dT primers for cDNA synthesis
(Qiagen GmbH, Hilden, Germany). For quantitative PCR
with Light Cycler (Bio-Rad iCycler iQ5, Bio-Rad Inc., Her-
cules, CA, USA) we used SYBR GreenER kit (SYBR
GreenER qPCR SuperMix, Invitrogen Corp., Karlsruhe,
Germany) according to the distributor's instructions.
Samples were tested as dublicates whereas deviations of
1,5 threshold cycles were tolerated. For data evaluation
the  ΔΔCT-method was used and only threshold cycles
before cycle 35 were defined as valid.
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Table 2: Expression rates of desmin, MyoD and MEF-2d
Primer qPCR Desmin MyoD MEF-2 GAPDH
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